| Cat.No. |
Product Name |
Information |
Area |
| T7082 |
HDAC8-IN-1 |
MDK-7933 (HDAC8-IN-1) is a HDAC8 inhibitor with an IC50 of 27.2 nM in cancer cell lin... |
|
| T3983 |
TMP 195 |
TMP195 is a selective class IIa histone deacetylase (HDAC) inhibitor. |
Others |
| T3516 |
Minomustine |
EDO-S101 is a pan HDAC inhibitor with IC50 values of 9, 9 and 25 nM for HDAC1, HDAC2 ... |
Others |
| T3509 |
ACY-738 |
ACY-738 demonstrates inhibitory activity against recombinant HDAC6 (IC50: 1.7 nM), wi... |
Others |
| T3937 |
Methyl L-histidinate dihydrochloride |
Inhibition of histidine decarboxylase in Sprague-Dawley rat stomach assessed as decre... |
|
| T3878 |
Raddeanin A |
Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Ra... |
Others |
| T3499 |
Remodelin |
Remodelin is an effective and specific inhibitor of the acetyl-transferase protein NA... |
Cancer |
| T6980 |
Scriptaid |
Scriptaid is an inhibitor of HDAC，and has a greater effect on acetylated H4 than H3. |
Others |
| T3661 |
Citarinostat |
ACY-241, also known as Citarinostat, is a potent, selective and orally available hist... |
Cancer |
| T6865 |
Quisinostat 2HCl |
Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with high... |
Others |
| T6270 |
Trichostatin A |
Trichostatin A is a natural derivative of dienohydroxamic acid isolated from species ... |
Cancer |
| T1558 |
Resveratrol |
Resveratrol is a polyphenolic phytoalexin with antioxidant and potential chemoprevent... |
Cancer |
| T3205 |
UF010 |
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μM and... |
Cancer |
| T3204 |
BML-210 |
BML-210 is a new-type HDAC inhibitor. |
Cancer |
| T3199 |
PTACH |
PTACH (NCH-51) is a SAHA-based inhibitor of human HDAC. It can potently inhibit the g... |
Cancer |
| T3193 |
Pimelic diphenylamide 106 |
Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (with IC... |
Cancer |
| T6639 |
RG2833 |
RG2833 (RGFP109), a brain-penetrant HDAC inhibitor, is with IC50 of 60 nM and 50 nM ... |
Cancer |
| T6421 |
BRD73954 |
BRD73954, an effective and specific HDAC inhibitor, which is with IC50 of 36 nM and 1... |
Cancer |
| T6362 |
4SC-202 |
4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57... |
Cancer |
| T6637 |
Resminostat |
Resminostat is an orally bioavailable inhibitor of histone deacetylases (HDACs) with ... |
Cancer |
| T6481 |
Droxinostat |
Droxinostat is a selective inhibitor of HDAC, mostly for HDACs 6 and 8 with IC50 of 2... |
Cancer |
| T6695 |
Tasquinimod |
Tasquinimod is a quinoline-3-carboxamide linomide analog with antiangiogenic and pote... |
Cancer |
| T6233 |
Entinostat |
Entinostat (MS-275) is an effective inhibitor of HDAC1 and HDAC3. The IC50 of Entinos... |
Cancer |
| T6161 |
Tubastatin A HCl |
Tubastatin A HCl is an effective and specific HDAC6 inhibitor (IC50: 15 nM). It has s... |
Others |
| T6061 |
LMK-235 |
LMK-235 is a potent HDAC inhibitor, and is used in cancer research. |
Cancer |
| T6055 |
Quisinostat |
Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest p... |
Cancer |
| T6006 |
Romidepsinhot |
Romidepsin is an intravenously administered histone deacetylase inhibitor and antineo... |
Cancer |
| T3108 |
CUDC-101 |
CUDC-101 is a potent inhibitor of HDAC, EGFR and HER2 with IC50s of 4.4, 2.4 and 15.7... |
Cancer |
| T2512 |
Mocetinostat |
Mocetinostat (MGCD0103) is an orally available, Class 1-selective and small molecule ... |
Cancer |
| T2489 |
Rocilinostat |
Ricolinostat is an orally bioavailable, specific inhibitor of histone deacetylase 6 (... |
Cancer |
sales@targetmol.com (US) / info@targetmol.com Tel: (781) 999-4286 / (781) 999-5354
